1. Home
  2. MRVI vs BBNX Comparison

MRVI vs BBNX Comparison

Compare MRVI & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$4.83

Market Cap

559.0M

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$9.70

Market Cap

493.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
BBNX
Founded
2014
2015
Country
United States
United States
Employees
N/A
423
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
559.0M
493.1M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
MRVI
BBNX
Price
$4.83
$9.70
Analyst Decision
Buy
Strong Buy
Analyst Count
4
10
Target Price
$4.13
$23.80
AVG Volume (30 Days)
1.8M
1.1M
Earning Date
05-07-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
N/A
Revenue This Year
$12.54
$34.90
Revenue Next Year
$7.87
$34.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.99
$8.80
52 Week High
$4.11
$32.71

Technical Indicators

Market Signals
Indicator
MRVI
BBNX
Relative Strength Index (RSI) 80.65 40.16
Support Level $3.27 $9.42
Resistance Level N/A $11.92
Average True Range (ATR) 0.23 0.78
MACD 0.10 -0.09
Stochastic Oscillator 98.48 5.14

Price Performance

Historical Comparison
MRVI
BBNX

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: